Yahoo
NYSE - Delayed Quote USD

Standex International Corporation (SXI)

243.55 -4.64 (-1.87%)
At close: 4:00:02 PM EDT
243.55 0.00 (0.00%)
After hours: 4:01:21 PM EDT
Trade SXI on Coinbase
SXI Q1 2027 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for SXI
  • Previous Close 248.19
  • Open 256.76
  • Bid 226.30 x 8000
  • Ask 257.21 x 20000
  • Day's Range 234.83 - 256.76
  • 52 Week Range 215.62 - 363.89
  • Volume 223,097
  • Avg. Volume 138,004
  • Market Cap (intraday) 2.991B
  • Beta (5Y Monthly) 1.07
  • PE Ratio (TTM) 28.06
  • EPS (TTM) 8.68
  • Earnings Date (est.) Jan 28, 2027
  • Forward Dividend & Yield 1.44 (0.58%)
  • 1y Target Est 332.40
  • Zacks Rating Neutral

Standex International Corporation, through it subsidiaries, engages in the manufacture and sale of products and services for commercial and industrial markets in the United States and internationally. It operates through Electronics, Aerospace & Defense, Scientific, Engraving & Hydraulics segments. The company offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, custom electronic and current sensors, instrument transformers, wound transformers, bushings, inductors, current sense and planar transformer technology, value added assemblies, mechanical packaging applications under the Standex Electronics, Standex-Meder Electronics, Renco Electronics, Northlake Engineering, Agile Magnetics, Sensor Solutions, Standex Electronics Japan, Minntronix, Nascentechnology, Sanyu, Amran Instruments, and Narayan Powertech brands. It also provides mold texturizing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery services under the Mold Tech, Piazza Rosa, World Client Services, Tenibac-Graphion, GS Engineering, and Innovent and Custom Hoists brands. In addition, it provides specialty temperature-controlled equipment for medical, scientific, pharmaceutical, biotech, and industrial markets under the American BioTech Supply, Lab Research Products, Corepoint, Cryosafe, CryoGuard, and Custom Biogenic Systems brands; and net and near net formed single-source customized solutions for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets under the Spincraft and McStarlite brands. Further, it offers refrigerated, heated, display cases, single and double acting telescopic, and piston rod hydraulic cylinders under the Federal and Custom Hoist brands. The company was founded in 1955 and is headquartered in Salem, New Hampshire.

www.standex.com

4,100

Full Time Employees

June 30

Fiscal Year Ends

Industrials

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SXI
12.50%
S&P 500 (^GSPC)
10.73%

1-Year Return

SXI
2.54%
S&P 500 (^GSPC)
11.11%

3-Year Return

SXI
73.96%
S&P 500 (^GSPC)
81.91%

5-Year Return

SXI
127.54%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 232.57M
Earnings 24.17M
Profit Margin 10.39%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
50M
100M
150M
200M
10.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

310.00
332.40 Average
243.55 Current
350.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/14/2026
Analyst JP Morgan
Rating Action Initiated
Rating Neutral
Price Action Announces
Price Target 320

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.73%

  • Return on Assets (ttm)

    6.06%

  • Return on Equity (ttm)

    17.22%

  • Revenue (ttm)

    891.6M

  • Net Income Avi to Common (ttm)

    104.78M

  • Diluted EPS (ttm)

    8.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    181.04M

  • Total Debt/Equity (mrq)

    74.99%

  • Levered Free Cash Flow (ttm)

    165.31M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: